Correctors modify the bicarbonate permeability of F508del-CFTR

被引:24
作者
Fiore, Michele [1 ]
Picco, Cristiana [1 ]
Moran, Oscar [1 ]
机构
[1] CNR, Ist Biofis, Via Marini 6, I-16149 Genoa, Italy
关键词
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; CHLORIDE CHANNELS; CFTR; DELTA-F508; EXPRESSION; SECRETION; MECHANISM; MEMBRANE; MUTATION;
D O I
10.1038/s41598-020-65287-4
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
One of the most common mutations in Cystic Fibrosis (CF) patients is the deletion of the amino acid phenylalanine at position 508. This mutation causes both the protein trafficking defect and an early degradation. Over time, small molecules, called correctors, capable of increasing the amount of mutated channel in the plasma membrane and causing an increase in its transport activity have been developed. This study shows that incubating in vitro cells permanently transfected with the mutated channel with the correctors VX809, VX661 and Corr4a, and the combination of VX809 and Corr4a, a recovery of anion transport activity is observed. Interestingly, the permeability of bicarbonate increases in the cells containing corrected p.F508del CFTR channels is greater than the increase of the halide permeability. These different increases of the permeability of bicarbonate and halides are consistent with the concept that the structural conformation of the pore of the corrector-rescued p.F508del channels would be different than the normal wild type CFTR protein.
引用
收藏
页数:7
相关论文
共 50 条
[1]   Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors [J].
Amico, Giulia ;
Brandas, Chiara ;
Moran, Oscar ;
Baroni, Debora .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
[2]   Reversing the waste paradigm Waste Architecture Platform and beyond Introduction [J].
Artuso, Anna ;
Cossu, Elena .
RI VISTA-RICERCHE PER LA PROGETTAZIONE DEL PAESAGGIO, 2018, (01) :9-11
[3]   Functional and pharmacological induced structural changes of the cystic fibrosis transmembrane conductance regulator in the membrane solved using SAXS [J].
Baroni, Debora ;
Zegarra-Moran, Olga ;
Moran, Oscar .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2015, 72 (07) :1363-1375
[4]   Cystic fibrosis: A worldwide analysis of CFTR mutations - Correlation with incidence data and application to screening [J].
Bobadilla, JL ;
Macek, M ;
Fine, JP ;
Farrell, PM .
HUMAN MUTATION, 2002, 19 (06) :575-606
[5]   Cloning and functional expression of a human kidney Na+:HCO3- cotransporter [J].
Burnham, CE ;
Amlal, H ;
Wang, ZH ;
Shull, GE ;
Soleimani, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (31) :19111-19114
[6]   CFTR structure and cystic fibrosis [J].
Cant, Natasha ;
Pollock, Naomi ;
Ford, Robert C. .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2014, 52 :15-25
[7]   Cystic fibrosis: a clinical view [J].
Castellani, Carlo ;
Assael, Baroukh M. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2017, 74 (01) :129-140
[8]   Potentiator ivacaftor abrogates pharmacological correction of ΔF508 CFTR in cystic fibrosis [J].
Cholon, Deborah M. ;
Quinney, Nancy L. ;
Fulcher, M. Leslie ;
Esther, Charles R., Jr. ;
Das, Jhuma ;
Dokholyan, Nikolay V. ;
Randell, Scott H. ;
Boucher, Richard C. ;
Gentzsch, Martina .
SCIENCE TRANSLATIONAL MEDICINE, 2014, 6 (246)
[9]   ALTERED CHLORIDE-ION CHANNEL KINETICS ASSOCIATED WITH THE DELTA-F508 CYSTIC-FIBROSIS MUTATION [J].
DALEMANS, W ;
BARBRY, P ;
CHAMPIGNY, G ;
JALLAT, S ;
DOTT, K ;
DREYER, D ;
CRYSTAL, RG ;
PAVIRANI, A ;
LECOCQ, JP ;
LAZDUNSKI, M .
NATURE, 1991, 354 (6354) :526-528
[10]   Identification of GLPG/ABBV-2737, a Novel Class of Corrector, Which Exerts Functional Synergy With Other CFTR Modulators [J].
de Wilde, Gert ;
Gees, Maarten ;
Musch, Sara ;
Verdonck, Katleen ;
Jans, Mia ;
Wesse, Anne-Sophie ;
Singh, Ashvani K. ;
Hwang, Tzyh-Chang ;
Christophe, Thierry ;
Pizzonero, Mathieu ;
Van der Plas, Steven ;
Desroy, Nicolas ;
Cowart, Marlon ;
Stouten, Pieter ;
Nelles, Luc ;
Conrath, Katja .
FRONTIERS IN PHARMACOLOGY, 2019, 10